Summary

US Medical Second Opinion Market Research Report Information Based on Diagnosis (Cancer Cardiovascular disease, Spine Procedures, Neurology Conditions, Others), by Service Provider (Hospitals Physicians/Specialists, Medical Second Opinion Companies, Health Insurance Companies) by Mode of Payment (Online, Offline, and others) Forecast to 2030

Market Overview
US Medical Second Opinion Market is anticipated to register a healthy CAGR of 116.11% during the review period. The growth of the US medical second opinion market is attributed to the growing preference for healthcare cost optimization, the increased need to improve diagnosis and treatment planning, and the increasing number of cancer cases. However, the high cost of a medical second opinion and lack of awareness among people is anticipated to hamper the market growth.
A second doctor's opinion is used to either confirm or change the recommendations made by another physician for a course of therapy. Getting a second medical opinion may have a substantial impact on the diagnosis, course of therapy, and prognosis. By maximizing the course of treatment, the patient can reduce unneeded risks. Less exposure to legal claims benefits doctors, and improved care, quality control, and cost savings from unneeded operations and treatments benefit healthcare organizations. However, using this technology improperly can result in exorbitant medical expenses.
Market Segmentation
Based on diagnosis the US Medical Second Opinion Market is classified into Cancer Cardiovascular disease, Spine Procedures, Neurology Conditions, Others.
In terms of Service Providers, the market has been categorized into Hospitals Physicians/Specialists, Medical Second Opinion Companies, Health Insurance Companies.
Based on Mode of Payment the market is divided into Online, Offline, and others.
Major Players
The key players in the US Medical Second Opinion Market are SecondOpinionExpert, Inc., Included Health, Inc., AccessHope, LLC, and 2nd.MD.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 9
1.1 OVERVIEW 9
2 MARKET INTRODUCTION 10
2.1 DEFINITION 10
2.2 SCOPE OF THE STUDY 10
2.3 RESEARCH OBJECTIVE 10
2.4 MARKET STRUCTURE 10
2.5 ASSUMPTIONS & LIMITATIONS 11
3 RESEARCH METHODOLOGY 12
3.1 DATA MINING 12
3.2 SECONDARY RESEARCH 13
3.3 PRIMARY RESEARCH 14
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 15
3.5 FORECASTING TECHNIQUES 16
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 17
3.6.1 BOTTOM-UP APPROACH 17
3.6.2 TOP-DOWN APPROACH 18
3.7 DATA TRIANGULATION 18
3.8 VALIDATION 18
4 MARKET DYNAMICS 19
4.1 OVERVIEW 19
4.2 DRIVERS 20
4.2.1 GROWING PREFERENCE FOR HEALTHCARE COST OPTIMIZATION 20
4.2.2 INCREASING NEED TO IMPROVE DIAGNOSIS AND TREATMENT PLANNING 20
4.2.3 INCREASING NUMBER OF CANCER CASES 21
4.3 RESTRAINTS 22
4.3.1 HIGH COST OF MEDICAL SECOND OPINION 22
4.3.2 LACK OF AWARENESS AMONG PEOPLE 22
4.4 OPPORTUNITIES 23
4.4.1 RISING NUMBER OF STRATEGIC INITIATIVES 23
5 MARKET FACTOR ANALYSIS 24
5.1 VALUE CHAIN ANALYSIS 24
5.1.1 R&D 25
5.1.2 SERVICE 25
5.1.3 SALES AND MARKETING 25
5.1.4 CONTRACT MANAGEMENT 25
5.1.5 CUSTOMER SERVICE & SUPPORT 25
5.2 PORTER'S FIVE FORCES MODEL 26
5.2.1 THREAT OF NEW ENTRANTS 26
5.2.2 BARGAINING POWER OF SUPPLIERS 26
5.2.3 THREAT OF SUBSTITUTES 27
5.2.4 BARGAINING POWER OF BUYERS 27
5.2.5 INTENSITY OF RIVALRY 27
5.3 IMPACT OF COVID-19 ON THE US MEDICAL SECOND OPINION MARKET 27
5.3.1 IMPACT ON VALUE CHAIN 27
5.3.2 IMPACT ON DEMAND 27
5.3.3 IMPACT ON REGION 28
5.3.4 IMPACT ON KEY PLAYERS 28
6 US MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS 29
6.1 OVERVIEW 29
6.2 CANCER 30
6.3 CARDIOVASCULAR/HEART DISORDERS 31
6.4 SPINE PROCEDURES 33
6.5 NEUROLOGY CONDITIONS 34
6.6 OTHERS 34
7 US MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER 35
7.1 OVERVIEW 35
7.2 HOSPITALS PHYSICIANS/SPECIALTIES 36
7.3 ONLINE PHYSICIANS PORTAL 36
7.4 MEDICAL SECOND OPINION COMPANIES 36
7.5 HEALTH INSURANCE COMPANIES 36
8 US MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT 37
8.1 OVERVIEW 37
8.2 ONLINE PAYMENT 38
8.3 OFFLINE PAYMENT 38
9 COMPANY PROFILES 39
9.1 SECONDOPINIONEXPERT, INC. 39
9.1.1 COMPANY OVERVIEW 39
9.1.2 FINANCIAL OVERVIEW 39
9.1.3 PRODUCTS OFFERED 39
9.1.4 KEY DEVELOPMENTS 39
9.1.5 SWOT ANALYSIS 40
9.1.6 KEY STRATEGIES 40
9.2 INCLUDED HEALTH, INC. 41
9.2.1 COMPANY OVERVIEW 41
9.2.2 FINANCIAL OVERVIEW 41
9.2.3 PRODUCTS OFFERED 41
9.2.4 KEY DEVELOPMENTS 41
9.2.5 SWOT ANALYSIS 42
9.2.6 KEY STRATEGIES 42
9.3 ACCESSHOPE, LLC 43
9.3.1 COMPANY OVERVIEW 43
9.3.2 FINANCIAL OVERVIEW 43
9.3.3 PRODUCTS OFFERED 43
9.3.4 KEY DEVELOPMENTS 43
9.3.5 SWOT ANALYSIS 44
9.3.6 KEY STRATEGIES 44
9.4 NAVVISA 45
9.4.1 COMPANY OVERVIEW 45
9.4.2 FINANCIAL OVERVIEW 45
9.4.3 SERVICES OFFERED 45
9.4.4 KEY DEVELOPMENTS 45
9.4.5 KEY STRATEGIES 45
9.5 2ND.MD 46
9.5.1 COMPANY OVERVIEW 46
9.5.2 FINANCIAL OVERVIEW 46
9.5.3 SERVICES OFFERED 46
9.5.4 SWOT ANALYSIS 47
9.5.5 KEY DEVELOPMENTS 47
9.5.6 KEY STRATEGIES 47
10 APPENDIX 48
10.1 REFERENCES 48
10.2 RELATED REPORTS 49